Ligand Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Ligand Pharma (LGND) Tops Q2 EPS by 13c
July 30, 2019 8:04 AM EDTLigand Pharma (NASDAQ: LGND) reported Q2 EPS of $0.68, $0.13 better than the analyst estimate of $0.55. Revenue for the quarter came in at $25 million versus the consensus estimate of $21.01 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
... More